NEW YORK (CBSNewYork/AP) — Mets ace Matt Harvey is hoping to avoid Tommy John surgery. He was diagnosed with a partially torn ulnar collateral ligament, but tweeted Tuesday that he'll be back on the mound next April.
New York manager Terry Collins says Harvey was encouraged after talking to other pitchers who had similar symptoms or injuries and didn't require surgery, including Philadelphia Phillies starter Roy "Doc" Halladay.
"It just sounded similar to what I had," Halladay said Wednesday. "I was talking to Terry Collins, and he asked if I'd talk to him. We just talked a little bit about some of the strengthening stuff I did. Most every pitcher is going to have changes in the UCL ... it sounded to me that it's very similar to what I had."
He added: "I just shared that with him and what I went through. (Dr. James) Andrews had told me that they felt like at some point they would have to go in and repair it. That was eight years ago, and I've never had an issue since."
Collins said Harvey was "down in the dumps" before his talk with Halladay. Still, Harvey wouldn't talk about the chat.
"I gave a press conference," he said.
The Mets said no decision will be made until Harvey is re-examined in a few weeks after the swelling subsides.
"You just hope once the inflammation goes down they get a chance to look at it and it's not something they have to fix," Halladay said.
The Mets also announced that Jenrry Mejia and Jeremy Hefner have undergone elbow surgery.
Mejia had a bone spur removed and hopes to be ready for the start of next season. Hefner had Tommy John surgery and will likely be sidelined at least a year. Both operations were performed Wednesday by Mets medical director Dr. David Altchek.
You May Also Be Interested In These Stories
(TM and © Copyright 2013 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2013 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)
for more features.